Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Circadian Rhythms and Gene Regulation02:19

Circadian Rhythms and Gene Regulation

The biological clock is involved in many aspects of regulating complex physiology in all animals. It was in 1935 when German zoologists, Hans Kalmus and Erwin Bünning, discovered the existence of circadian rhythm in Drosophila melanogaster. However, the internal molecular mechanisms behind the circadian clock remained a mystery until 1984, when Jeffrey C. Hall, Michael Rosbash, and Michael W. Young discovered the expression of the Per gene oscillating over a 24-hour cycle. In subsequent years,...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Understanding Sleep01:11

Understanding Sleep

Sleep, an essential biological state, involves significant reductions in physical activity, sensory awareness, and interaction with the environment. This complex physiological process is primarily regulated by specific brain regions, notably the hypothalamus and pons, which govern the sleep-wake cycle or circadian rhythm.
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronobiotic and cytoprotective activity of melatonin in the cardiovascular system. Doses matter.

Npj biological timing and sleep·2026
Same author

Rethinking Melatonin Dosing: Safety and Efficacy at Higher-than-Usual Levels in Aged Patients with Sleep Disturbances and Comorbidities.

Brain sciences·2025
Same author

Efficacy of a Neuroimmune Therapy Including Pineal Methoxyindoles, Angiotensin 1-7, and Endocannabinoids in Cancer, Autoimmune, and Neurodegenerative Diseases.

Clinical interventions in aging·2025
Same author

Effect of Bisphenol A on the neuro-immune-endocrine mechanisms controlling the reproductive axis response during an inflammatory event.

Environmental toxicology and pharmacology·2025
Same author

Function of intramitochondrial melatonin and its association with Warburg metabolism.

Cellular signalling·2025
Same author

Melatonin stabilizes atherosclerotic plaques: an association that should be clinically exploited.

Frontiers in medicine·2024

Related Experiment Video

Updated: May 24, 2026

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

Melatonin and mitochondrial dysfunction in the central nervous system.

Daniel P Cardinali1, Eleonora S Pagano, Pablo A Scacchi Bernasconi

  • 1Pontificia Universidad Católica Argentina, Facultad de Ciencias Médicas, 1107 Buenos Aires, Argentina. danielcardinali@uca.edu.ar

Hormones and Behavior
|March 7, 2012
PubMed
Summary

Melatonin protects mitochondria from dysfunction implicated in neurodegenerative diseases like Alzheimer's and Parkinson's. Clinical trials with higher melatonin doses are needed to confirm its therapeutic potential for these conditions.

More Related Videos

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Related Experiment Videos

Last Updated: May 24, 2026

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry
08:19

Assessing Mitochondrial Function in Sciatic Nerve by High-Resolution Respirometry

Published on: May 5, 2022

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models
08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Area of Science:

  • Neuroscience
  • Mitochondrial Biology
  • Pharmacology

Background:

  • Mitochondrial dysfunction is a key factor in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD).
  • Impaired mitochondrial function involves increased free radicals, nitric oxide (NO) production, and disrupted electron transport.
  • Melatonin, a pineal gland hormone, is a potent antioxidant with demonstrated protective effects on mitochondrial bioenergetics.

Purpose of the Study:

  • To investigate the role of melatonin in preventing mitochondrial dysfunction in experimental models of neurodegenerative diseases.
  • To assess the therapeutic potential of melatonin and its analogs in neurodegenerative disorders.

Main Methods:

  • In vitro and in vivo studies using experimental models of AD, PD, and HD.
  • Evaluation of melatonin's protective effects against oxidative and nitrosative stress-induced mitochondrial dysfunction.
  • Review of existing clinical studies on melatonin and its analogs for sleep and circadian rhythm disruption.

Main Results:

  • Melatonin effectively prevented mitochondrial dysfunction in experimental models of AD, PD, and HD.
  • Melatonin exhibits selective uptake by mitochondria, a unique property among antioxidants.
  • Clinical studies show melatonin can improve sleep and circadian rhythm disturbances in AD and PD patients.

Conclusions:

  • Melatonin demonstrates significant potential in protecting against mitochondrial dysfunction relevant to neurodegeneration.
  • Higher clinical doses (50-100mg/day) of melatonin warrant investigation for therapeutic efficacy in neurodegenerative diseases.
  • Further research into melatonin analogs with prolonged effects is ongoing for various patient groups.